6.7 C
New York
Friday, March 29, 2024

PBTH & VPHM

TA and analysis on a couple biotechs by Allan, with seal of agreement by Pharmboy, at PSW, and seal of recent insider buying (albeit 10% owners) for VPHM. These companies are presenting at conferences this week, and the stocks are highly volatile and risky, and that sword cuts both ways. So keep in mind the "sell on the news" phenomenon. – Ilene 

PBTH & VPHM

PBTH 

Fundamentals:

Pipeline Covering An Existing $25 billion Market

Human growth hormone ($3 billion market, entering Phase II) that could potentially be injected twice per month instead of daily injections. Interferon beta for multiple sclerosis ($4.5 billion market) that may have dramatically lower side effects. Our CTP-enhanced therapeutic proteins pipeline has the potential to dominate a $25 billion market.

CTP — Nature’s Solution To Proteins’ Longevity

CTP is a small peptide naturally found in the body as a portion of the hormone hCG, and in fact provides hCG with its superior longevity. We attach CTP to other proteins and significantly increase their lonevity as well.

Merck’s FSH-CTP Approved In Europe Jan 2010
Merck and PROLOR have the exclusive license from Washington University to utilize the CTP technology. On January 28, 2010 the European Commission (EC) gave Merck & Co. marketing approval with unified labeling valid in all European Union Member States for FSH-CTP, now branded as ELONVA®

Trend Models

 

VPHM 

Fundamentals:  

This is a list of insider-Buys for VPHM for the past year.  Note that the last time the "Baker Brothers" (10% owner) bought shares was a year ago and at $6 a share.  One year later and at $13 a share, they are buying again.  Note also the size of the I-Buy, almost 2,000,000 shares, way more then a year ago at half the share price.  Significant?  

Trend Models

An interesting feature shared by both of these picks is that both company’s are making presentations at Biotechnology conferences this week, VPHM on Tuesday and PBTH on Wednesday. Two stocks with their own stories to tell and possibly catapult respective share prices.  It’s the game we choose to play.

*****

Allan’s newly launched newsletter, “Trend Following Trading Model,” goes with the trend-following trading system he’s been working on for years. Most trades last for weeks to months. Allan’s offering PSW readers a special 25% discount. Click here. For a more detailed introduction, read this introductory article.

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,450FansLike
396,312FollowersFollow
2,280SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x